Israel Englander’s Journey Medical DERM Stock Holding History

Israel Englander’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$779K	Sell	110,016 -273,051	-71%	-$1.56M	﹤0.01%	4491
2026 Q1	$1.8M	Sell	383,067 -74,745	-16%	-$580K	﹤0.01%	3975
2025 Q4	$3.53M	Buy	+457,812	New	+$3.59M	﹤0.01%	3393
2025 Q2	–	Sell	-21,473	Closed	-$127K	–	5937
2025 Q1	$127K	Buy	+21,473	New	+$106K	﹤0.01%	5398
2024 Q2	–	Sell	-36,117	Closed	-$133K	–	5997
2024 Q1	$133K	Sell	36,117 -38,914	-52%	-$169K	﹤0.01%	5505
2023 Q4	$432K	Buy	75,031 +60,569	+419%	+$270K	﹤0.01%	4728
2023 Q3	$39.6K	Buy	+14,462	New	+$32.3K	﹤0.01%	5527
2022 Q2	–	Sell	-21,449	Closed	-$103K	–	7064
2022 Q1	$103K	Buy	+21,449	New	+$107K	﹤0.01%	6125

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Israel Englander's DERM Position: Q2 2026 in Review

Israel Englander reduced its Journey Medical (DERM) stake by 71% in Q2 2026, selling an estimated $1.56M and leaving 110,016 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #4491.

Israel Englander first reported a position in DERM in Q1 2022 and has held it in 8 quarters since. The position peaked at $3.53M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Israel Englander held 110,016 shares of Journey Medical worth $779K as of Q2 2026.
Israel Englander sold 273,051 Journey Medical shares in Q2 2026, an estimated $1.56M.
Journey Medical made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4491 holding.
Israel Englander first reported a position in Journey Medical in Q1 2022 and has held it in 8 quarters since.
Israel Englander's Journey Medical position peaked at $3.53M in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.